Table 1.
Treatment group | Experimental biological product and (estimated dose) | No. of animals | Route of administration | Challenge |
---|---|---|---|---|
T01 | PBS (Negative control) | 8 | s/c | B. bronchiseptica |
T02 | Bronchicine CAe (Positive control) | 8 | s/c | B. bronchiseptica |
T03 | BbBG – 7 (~1 × 107 BG particles) | 8 | s/c | B. bronchiseptica |
T04 | BbBG – 5 (~1 × 105 BG particles) | 8 | s/c | B. bronchiseptica |
PBS, phosphate buffer saline; BbBG, B. bronchiseptica Bacterial Ghosts; s/c, sub cutaneous.